Table 6.
PBDE levels in maternal and fetal blood
Country | Year | N | Maternal blood | Fetal blood | Most prominent BDE congener | Reference |
---|---|---|---|---|---|---|
U.S.A. | 1997–99 | 50 | <10–511 (10) | ND | * | Petreas et al. 2003 |
U.S.A. | 1999–01 | 24 | 5.3–320 (21) | ND | BDE-47 | Bradman et al. 2007 |
U.S.A. | 2001 | 15 | 15–580 (580) | 14–460 (39) | BDE-47 | Mazdai et al. 2003 |
Sweden | 2000–01 | 15 | 0.71–8.39 (2.07) | 0.46–4.28 (1.69) | BDE-47 | Meironyte Guvenius et al. 2003 |
France | 2005 | 26 | 0.21–1.91 (0.69) | 0.14–1.08 (0.41) | ** | Antignac et al. 2006 |
Japan | ND | 89 | 0.74–21.19 (2.99) | ND | BDE-209 | Inoue et al. 2006 |
China | ND | 21 | 1.6–17 (4.4) | 1.5–12 (3.9) | BDE-47
BDE-153 (fetus) |
Bi et al. 2006 |
Values of ΣPBDE levels are expressed as ng/g lipid. Results indicate range and median (in parenthesis).
BDE-47 only;
BDE-153 only. ND = not determined.